Aquestive Therapeutics, Inc. (AQST) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US03843E1047
Aquestive Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 44.55 m USD |
| Gross profit | 25.99 m USD |
| Operating income | -71.05 m USD |
| EBIT | -72.66 m USD |
| Net income | -83.78 m USD |
| Diluted EPS – continuing operations | -0.78 USD |
Full history since 2005, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film formulation of apomorphine; and AZSTARYS, an fda-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.
More stocks
- Starling Oncology, Inc. (STLN)
- Shenzhen Chuangyitong Technology Co.Ltd. (300991.SZ)
- Phathom Pharmaceuticals, Inc. (PHAT)
- Baotou Dongbao Bio-Tech Co Ltd (300239.SZ)
- Great Taipei Gas Corp (9908.TW)
- Unizyx Holding Corp (3704.TW)
- FOSTER L B CO (FSTR)
- Impulse Qingdao Health Tech Co Ltd (002899.SZ)
- Yuancheng Cable Co Ltd (002692.SZ)
- Shandong Donghong Pipe Ind Co (603856.SS)
- Shenzhen Emperor Technology Co Ltd (300546.SZ)
- Zinzino AB (ZZ B.ST)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.